Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
Sanofi (NASDAQ:SNY), in partnership with Vietnam Vaccine JSC (VNVC), officially launched a state-of-the-art vaccine production facility in Vietnam, marking a major step in boosting the country’s pharmaceutical manufacturing capabilities. The new plant is designed to supply vaccines for both domestic distribution and global export, supporting broader public health goals across Asia and beyond.
The inauguration ceremony, held on Tuesday, was attended by French President Emmanuel Macron during his diplomatic visit to the Southeast Asian nation, underscoring the importance of international collaboration in advancing healthcare access.
Strategically located to serve Vietnam’s growing healthcare needs, the facility enhances local vaccine self-sufficiency while contributing to the global vaccine supply chain. It is part of Sanofi’s ongoing effort to expand its footprint in emerging markets and reinforce its role as a global vaccine leader.
The launch comes amid heightened global attention on vaccine access and preparedness following recent pandemics. By leveraging cutting-edge technology and Sanofi’s extensive vaccine expertise, the facility aims to strengthen Vietnam’s position as a regional hub for pharmaceutical innovation and production.
This initiative reflects Sanofi’s commitment to investing in sustainable healthcare infrastructure and VNVC’s mission to improve immunization access across Vietnam. The collaboration also aligns with government goals to attract high-quality foreign investment in biotechnology and life sciences.
With the new facility operational, Sanofi and VNVC are well-positioned to meet growing demand for essential vaccines, not only within Vietnam but across neighboring countries, contributing to improved regional health outcomes.
The opening of this manufacturing site marks a significant milestone in Vietnam’s healthcare development, offering long-term benefits in vaccine accessibility, economic growth, and international cooperation in the pharmaceutical sector.
